Abstract
Sjogren’s syndrome is associated with chronic cough, but sicca symptoms are missing from cough evaluation guidelines. We evaluated patients with unexplained cough for undiagnosed Sjogren’s syndrome. Patients referred to our pulmonary clinic (Sheba Medical Center, 2009 to 2012) with unexplained cough and concomitant dry eyes were selected for evaluation. Unexplained cough was defined as chronic cough of unknown etiology despite algorithm-based evaluation and treatment. Patients were evaluated in a dedicated clinic by a pulmonologist, rheumatologist, and ophthalmologist specializing in autoimmune disease. Patients completed the Leicester Cough Questionnaire, spirometry, antibody testing for anti Ro/La, ophthalmologic examination with visual acuity, eyelid, ocular surface fluorescein staining, tear break-up time and Schirmer’s test, full slit lamp, and fundus examinations. Four-year follow-up was conducted by telephone questionnaire. We identified 24 patients among which 22 (21 females) agreed for evaluation. Eight patients (36%), seven initially, and one during follow-up were diagnosed with Sjogren’s syndrome (SS) (six secondary and two primary SS). At 4-year follow-up, cough tended to persist and improve in only 37% with SS. These include 2 (Scl and RA) who received rituximab and 1 (stage 1 sarcoidosis) with spontaneous improvement. In contrast, cough improved in most (64%) patients without SS; the majority (eight/nine) report intensified disease-specific treatment (five allergic and three GERD). We describe patients in whom unexplained chronic cough was associated with dry eyes. Focused workup revealed undiagnosed Sjogren’s syndrome in 36%. Dry eyes, with or without SS, is under-recognized and should be added to diagnostic algorithms for unexplained cough.
Similar content being viewed by others
Abbreviations
- SS:
-
Sjogren’s syndrome
- UIP:
-
Usual interstitial pneumonitis
- LIP:
-
Lymphocytic interstitial pneumonia
- MSGB:
-
Minor salivary gland biopsy
- GERD:
-
Gastroesophageal reflux disease
References
Birring SS, Prudon B, Carr AJ, Singh SJ, Morgan MD, Pavord ID (2003) Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax 58(4):339–343
Morice AH, Fontana GA, Sovijarvi AR, Pistolesi M, Chung KF, Widdicombe J, O’Connell F, Geppetti P, Gronke L, De Jongste J, Belvisi M, Dicpinigaitis P, Fischer A, McGarvey L, Fokkens WJ, Kastelik J, Force ERST (2004) The diagnosis and management of chronic cough. Eur Respir J 24(3):481–492. https://doi.org/10.1183/09031936.04.00027804
Irwin RS, Baumann MH, Bolser DC, Boulet LP, Braman SS, Brightling CE, Brown KK, Canning BJ, Chang AB, Dicpinigaitis PV, Eccles R, Glomb WB, Goldstein LB, Graham LM, Hargreave FE, Kvale PA, Lewis SZ, McCool FD, McCrory DC, Prakash UB, Pratter MR, Rosen MJ, Schulman E, Shannon JJ, Smith Hammond C, Tarlo SM, American College of Chest P (2006) Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest 129(1 Suppl):1S–23S. https://doi.org/10.1378/chest.129.1_suppl.1S
Morice AH, McGarvey L, Pavord I, British Thoracic Society Cough Guideline G (2006) Recommendations for the management of cough in adults. Thorax 61(Suppl 1):i1–24. https://doi.org/10.1136/thx.2006.065144
Kastelik JA, Aziz I, Ojoo JC, Thompson RH, Redington AE, Morice AH (2005) Investigation and management of chronic cough using a probability-based algorithm. Eur Respir J 25(2):235–243. https://doi.org/10.1183/09031936.05.00140803
Poe RH, Kallay MC (2003) Chronic cough and gastroesophageal reflux disease: experience with specific therapy for diagnosis and treatment. Chest 123(3):679–684
Smyrnios NA, Irwin RS, Curley FJ (1995) Chronic cough with a history of excessive sputum production. The spectrum and frequency of causes, key components of the diagnostic evaluation, and outcome of specific therapy. Chest 108(4):991–997
Irwin RS, Curley FJ, French CL (1990) Chronic cough. The spectrum and frequency of causes, key components of the diagnostic evaluation, and outcome of specific therapy. Am Rev Respir Dis 141(3):640–647. https://doi.org/10.1164/ajrccm/141.3.640
Corrao WM, Braman SS, Irwin RS (1979) Chronic cough as the sole presenting manifestation of bronchial asthma. N Engl J Med 300(12):633–637. https://doi.org/10.1056/NEJM197903223001201
Irwin RS, French CL, Curley FJ, Zawacki JK, Bennett FM (1993) Chronic cough due to gastroesophageal reflux. Clinical, diagnostic, and pathogenetic aspects. Chest 104(5):1511–1517
Kassan SS, Moutsopoulos HM (2004) Clinical manifestations and early diagnosis of Sjogren syndrome. Arch Intern Med 164(12):1275–1284. https://doi.org/10.1001/archinte.164.12.1275
Fahy JV, Dickey BF (2010) Airway mucus function and dysfunction. N Engl J Med 363(23):2233–2247. https://doi.org/10.1056/NEJMra0910061
Constantopoulos SH, Drosos AA, Maddison PJ, Moutsopoulos HM (1984) Xerotrachea and interstitial lung disease in primary Sjogren’s syndrome. Respiration 46(3):310–314
Strimlan CV, Rosenow EC 3rd, Divertie MB, Harrison EG Jr (1976) Pulmonary manifestations of Sjogren’s syndrome. Chest 70(03):354–361
Pratter MR, Brightling CE, Boulet LP, Irwin RS (2006) An empiric integrative approach to the management of cough: ACCP evidence-based clinical practice guidelines. Chest 129(1 Suppl):222S–231S. https://doi.org/10.1378/chest.129.1_suppl.222S
Irwin RS, Gutterman DD (2006) American College of Chest Physicians’ cough guidelines. Lancet 367(9515):981. https://doi.org/10.1016/S0140-6736(06)68414-6
Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, NR MI, RT MK, Wanger JS, Anderson SD, Cockcroft DW, Fish JE, Sterk PJ (2000) Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 161(1):309–329. https://doi.org/10.1164/ajrccm.161.1.ats11-99
Macintyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CP, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, Gustafsson P, Hankinson J, Jensen R, McKay R, Miller MR, Navajas D, Pedersen OF, Pellegrino R, Wanger J (2005) Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 26(4):720–735. https://doi.org/10.1183/09031936.05.00034905
Miller MR, Crapo R, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J, Force AET (2005) General considerations for lung function testing. Eur Respir J 26(1):153–161. https://doi.org/10.1183/09031936.05.00034505
Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J, Force AET (2005) Standardisation of spirometry. Eur Respir J 26(2):319–338. https://doi.org/10.1183/09031936.05.00034805
Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, Casaburi R, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson D, Macintyre N, McKay R, Miller MR, Navajas D, Pellegrino R, Viegi G (2005) Standardisation of the measurement of lung volumes. Eur Respir J 26(3):511–522. https://doi.org/10.1183/09031936.05.00035005
Ward N (2016) The Leicester Cough Questionnaire. J Physiother 62(1):53. https://doi.org/10.1016/j.jphys.2015.05.011
Nannini C, Jebakumar AJ, Crowson CS, Ryu JH, Matteson EL (2013) Primary Sjogren’s syndrome 1976–2005 and associated interstitial lung disease: a population-based study of incidence and mortality. BMJ Open 3(11):e003569. https://doi.org/10.1136/bmjopen-2013-003569
Ito I, Nagai S, Kitaichi M, Nicholson AG, Johkoh T, Noma S, Kim DS, Handa T, Izumi T, Mishima M (2005) Pulmonary manifestations of primary Sjogren’s syndrome: a clinical, radiologic, and pathologic study. Am J Respir Crit Care Med 171(6):632–638. https://doi.org/10.1164/rccm.200403-417OC
Parambil JG, Myers JL, Lindell RM, Matteson EL, Ryu JH (2006) Interstitial lung disease in primary Sjogren syndrome. Chest 130(5):1489–1495. https://doi.org/10.1378/chest.130.5.1489
Watanabe M, Naniwa T, Hara M, Arakawa T, Maeda T (2010) Pulmonary manifestations in Sjogren’s syndrome: correlation analysis between chest computed tomographic findings and clinical subsets with poor prognosis in 80 patients. J Rheumatol 37(2):365–373. https://doi.org/10.3899/jrheum.090507
Obenauf CD, Shaw HE, Sydnor CF, Klintworth GK (1978) Sarcoidosis and its ophthalmic manifestations. Am J Ophthalmol 86(5):648–655
Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H Jr, Bresnitz EA, De Palo L, Hunninghake G, Iannuzzi MC, Johns CJ, McLennan G, Moller DR, Newman LS, Rabin DL, Rose C, Rybicki B, Weinberger SE, Terrin ML, Knatterud GL, Cherniak R, Case Control Etiologic Study of Sarcoidosis research g (2001) Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 164(10 Pt 1):1885–1889. https://doi.org/10.1164/ajrccm.164.10.2104046
Lee HK, Kim DS, Yoo B, Seo JB, Rho JY, Colby TV, Kitaichi M (2005) Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. Chest 127(6):2019–2027
Liote H, Liote F, Seroussi B, Mayaud C, Cadranel J (2010) Rituximab-induced lung disease: a systematic literature review. Eur Respir J 35(3):681–687. https://doi.org/10.1183/09031936.00080209
La Corte R, Bajocchi G, Potena A, Govoni M, Trotta F (1995) Bronchial hyperreactivity in systemic sclerosis patients: influence of associated Sjogren’s syndrome. Ann Rheum Dis 54(8):636–639
Gudbjornsson B, Hedenstrom H, Stalenheim G, Hallgren R (1991) Bronchial hyperresponsiveness to methacholine in patients with primary Sjogren’s syndrome. Ann Rheum Dis 50(1):36–40
Bellido-Casado J, Plaza V, Diaz C, Geli C, Dominguez J, Margarit G, Torrejon M, Giner J (2011) Bronchial inflammation, respiratory symptoms and lung function in Primary Sjogren’s syndrome. Arch Bronconeumol 47(7):330–334. https://doi.org/10.1016/j.arbres.2011.01.003
Dalavanga YA, Constantopoulos SH, Galanopoulou V, Zerva L, Moutsopoulos HM (1991) Alveolitis correlates with clinical pulmonary involvement in primary Sjogren’s syndrome. Chest 99(6):1394–1397
Roy MG, Livraghi-Butrico A, Fletcher AA, McElwee MM, Evans SE, Boerner RM, Alexander SN, Bellinghausen LK, Song AS, Petrova YM, Tuvim MJ, Adachi R, Romo I, Bordt AS, Bowden MG, Sisson JH, Woodruff PG, Thornton DJ, Rousseau K, De la Garza MM, Moghaddam SJ, Karmouty-Quintana H, Blackburn MR, Drouin SM, Davis CW, Terrell KA, Grubb BR, O’Neal WK, Flores SC, Cota-Gomez A, Lozupone CA, Donnelly JM, Watson AM, Hennessy CE, Keith RC, Yang IV, Barthel L, Henson PM, Janssen WJ, Schwartz DA, Boucher RC, Dickey BF, Evans CM (2014) Muc5b is required for airway defence. Nature 505(7483):412–416. https://doi.org/10.1038/nature12807
Whitacre CC (2001) Sex differences in autoimmune disease. Nat Immunol 2(9):777–780. https://doi.org/10.1038/ni0901-777
Ezuddin NS, Alawa KA, Galor A (2015) Therapeutic strategies to treat dry eye in an aging population. Drugs Aging 32(7):505–513. https://doi.org/10.1007/s40266-015-0277-6
Paulsen AJ, Cruickshanks KJ, Fischer ME, Huang GH, Klein BE, Klein R, Dalton DS (2014) Dry eye in the beaver dam offspring study: prevalence, risk factors, and health-related quality of life. Am J Ophthalmol 157(4):799–806. https://doi.org/10.1016/j.ajo.2013.12.023
Moss SE, Klein R, Klein BE (2000) Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol 118(9):1264–1268
Bacman S, Perez Leiros C, Sterin-Borda L, Hubscher O, Arana R, Borda E (1998) Autoantibodies against lacrimal gland M3 muscarinic acetylcholine receptors in patients with primary Sjogren’s syndrome. Invest Ophthalmol Vis Sci 39(1):151–156
Dass S, Bowman SJ, Vital EM, Ikeda K, Pease CT, Hamburger J, Richards A, Rauz S, Emery P (2008) Reduction of fatigue in Sjogren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study. Ann Rheum Dis 67(11):1541–1544. https://doi.org/10.1136/ard.2007.083865
Acknowledgments
We sincerely appreciate the feedback and encouragement during our investigation from Dr. Burton Dickey of M.D., The University of Texas, M.D. Anderson Cancer Medical Center.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The study has been approved by the Helsinki committee of our institution. All persons gave their informed consent prior to their inclusion in the study. Details that might disclose the identity of the subjects under study should be omitted.
Disclosures
None.
Rights and permissions
About this article
Cite this article
Koslow, M., Kivity, S., Vishnevskia-Dai, V. et al. Unexplained cough: it is time to rule out Sjogren’s syndrome. Clin Rheumatol 37, 1215–1222 (2018). https://doi.org/10.1007/s10067-018-3987-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-018-3987-4